Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/19/21 → 6/30/24 |
Funding
- Syneos Health LLC: $35,383.00
BHV3000-311: Phase 3, Multicenter, Randomized, Double-Blind, Group Sequential, Placebo-Controlled Study to Assess Efficacy and Safety of Rimegepant for the Treatment of Migraine (With or Without Aura) in Children and Adolescents # 6 to <18 Years of Age
- Qaiser, Sharoon (PI)